Ingen internetforbindelse — viser den gemte version af siden.

Lisata Therapeuti…

USUSD
← Til screeneren

Lisata Therapeutics Inc. (LSE:0HS8) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
caladrius.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
New York City, United States
Ansatte
21
Grundlagt
2006
Udestående aktier
9.01 mio. pr. 2026-08-06
Free float
6.65 mio.
Markedsværdi
15.56 mio. USD
Insidere
22.26%
Institutionelle investorer
13.41%
Branche (SIC)
Pharmaceutical Preparations
ISIN
US1280583022
LEI
5493002287F62M3EGQ04
Beskrivelse

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksLSTA primærUSD1.21 -3.97%almindelige aktier
LSE London Stock Exchange0HS8 IOBUSD1.39 +0.00%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Ingen udbyttebetalinger fundet (tjekket 07.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
Deeter Investments Llp4.04%364 4792026-03-31
MAZZO DAVID J (Officer a…≈3.46%311 8902026-01-09
Vanguard Capital Managem…3.09%278 8372026-06-30
VANGUARD INDEX FUNDS-Van…2.12%191 3712026-06-30
Yakira Capital Managemen…1.54%138 5612026-06-30
CSS LLC1.23%110 4222026-06-30
AZAB MOHAMMAD (Director)≈1.16%104 9252026-01-09
KLOSK STEVEN MARK (Direc…≈1.06%95 8152026-01-09
BROWN GREGORY B (Directo…≈1.06%95 6592026-01-09
FLOWERS CYNTHIA LOUISE (…≈1.06%95 4462026-01-09
BUCK KRISTEN K (Officer)≈1.04%93 4622026-01-09
HENSON HEIDI (Director)≈0.95%85 7252026-01-09
Deltec Asset Management…0.92%83 1972026-06-30
Rangeley Capital, LLC0.9%81 0002026-06-30
VANGUARD INDEX FUNDS-Van…0.89%80 4442026-06-30
Geode Capital Management…0.81%72 6322026-06-30
Virtu Financial LLC0.65%58 7822026-06-30
Blackrock Inc.0.61%54 8572026-06-30
Vanguard Fiduciary Trust…0.54%48 9642026-06-30
Fidelity Concord Street…0.42%38 2752026-07-31
IMAM TARIQ (General Coun…≈0.4%36 0782026-01-09
NISCO JAMES (Officer)≈0.36%32 3112026-01-09
Fidelity Concord Street…0.12%10 3732026-07-31
VANGUARD VALLEY FORGE FU…0.08%7 0222026-06-30
Fidelity Concord Street…0.05%4 4272026-07-31
Fidelity Concord Street…0.05%4 3792026-07-31
DFA INVESTMENT DIMENSION…0.02%2 1852026-07-31
Dimensional ETF Trust-Di…0%1002026-07-31
Dimensional ETF Trust-Di…0%82026-07-31